In vitro fertilization and embryo transfer (IVF-ET) is considered a method of last resort for treating infertility. Oocytes taken from a woman are fertilized in vitro, and one or more resulting embryos are transferred into the uterus, with the hope that at least one will implant and result in pregnancy. Successful implantation depends on both embryo viability and uterine receptivity. This has led to the development of the EU model for embryo implantation, wherein uterine receptivity is characterized by a latent binary variable U and embryo viability is characterized by a latent binomial variable E representing the number of viable embryos among those selected for transfer. The observed number of implantations is the product of E and U .
INTRODUCTION
According to recent estimates, about 2.4 million American couples experience infertility (Winston and Handyside, 1993) . Among infertility treatments, in vitro fertilization-embryo transfer (IVF-ET, or IVF) is typically viewed as a method of last resort. Originally indicated primarily for infertility attributable to diseases of the Fallopian tubes, IVF is now used to treat a variety of other conditions, including male factor infertility.
IVF is carried out in several stages. First, the woman's ovaries are stimulated using hormonal therapy to achieve maturation of multiple oocytes. Mature oocytes are then retrieved from the ovaries and fertilization is attempted in vitro. If the fertilization process results in one or more embryos, a subset of these is transferred to the uterus. The number of implanted embryos is determined by counting gestational sacs observed via ultrasound. If no sacs are observed, or if the implantations do not lead to pregnancy, the IVF process may be repeated at a later menstrual cycle.
Understanding the role of various clinical conditions in the implantation process has become a critically important issue in IVF research. Presence of clinical complications can affect both the number of embryos transferred and any decisions to augment IVF with other, potentially invasive procedures. Practitioners usually transfer multiple embryos to increase the chance of at least one implantation (Walters, 1985; Rogers et al., 1986) , but this practice carries added risk of multiple gestation, which in turn may substantially increase prenatal morbidity and mortality (Callahan et al., 1994) .
Hydrosalpinx and implantation rate
One issue generating considerable recent controversy is how or even whether to treat women with hydrosalpinx, a relatively common complication among women with tubal disease. Hydrosalpinx is a condition characterized by excess amounts of fluid in the Fallopian tubes; the fluid can contain various micro-organisms, debris, and other matter (Shelton et al., 1996) . Even though IVF is designed to avoid tubal disease problems by circumventing tubal passage altogether, it has recently been suggested that presence of hydrosalpinx may reduce embryo implantation rates (Nackley and Muasher, 1998; Sharara et al., 1996; Shelton et al., 1996) . The potential reductions in implantation rate are thought to result from leakage of fluid to the uterine cavity, thereby compromising endometrial function and impairing development of implanting embryos. Hydrosalpinx is thought not to affect embryo viability prior to transfer because neither oocytes nor sperm are exposed to the fluid.
At issue is whether any reductions in implantation rate are substantial enough to warrant augmenting IVF with other procedures. Temporary treatment solutions include antibiotics and transvaginal drainage of the hydrosalpingeal fluid (Russell et al., 1991) . Another treatment option, at the center of current debate, is surgical removal of the hydrosalpinges. Although surgery may be more likely to prevent recurrence, it carries the nominal risks associated with anesthesia, and may result in interstitial pregnancy and irreversible damage to the tubes. Despite these risks, some investigators have recommended surgical treatment to maximize the likelihood of implantation. See Nackley et al. (1998) for a comprehensive review.
Structure of implantation data from IVF studies
The current statistical work is motivated by the need to analyze data from an ongoing study of the role of hydrosalpinx in IVF patients with tubal disease, at the Women and Infants' Hospital (WIH) in Providence, RI. In our analysis we use data from initial IVF cycles of 288 women, 81 of whom have hydrosalpinx. The data include number of transferred embryos, number of implantations, number of oocytes retrieved, and age. A premier analysis (Blazar et al., 1997) , found that crude implantation rates at Pennsylvania State University on February 28, 2013 http://biostatistics.oxfordjournals.org/ Downloaded from from all cycles (total implantations divided by total transfers) following IVF for women with and without hydrosalpinx are 8.5 and 11.2%, respectively. For woman i, where i = 1, . . . , n, let t i denote the number of embryos transferred, S i the number observed to implant, and θ the per-embryo implantation probability. A simple approach to analyzing implantation, and one adopted in most clinical publications on the topic, is to assume that S i are independent and identically distributed according to a binomial distribution with parameter θ . Recognizing that implantation is affected by both embryo viability and uterine receptivity, Speirs et al. (1983) , and later Walters (1985) and Rogers et al. (1986) proposed the so-called 'EU model', wherein the number of observed implantations is a product of the number E i of viable embryos and a binary indicator U i of uterine receptivity. Hence S i = U i E i , where U i follows a Bernoulli distribution with probability ρ and E i ∼ Bin(π, t i ).
By commonly used definition, embryo viability is an exclusive property of an individual embryo, determined (but not observable) prior to transfer. It can be characterized as whether the embryo would implant to a receptive uterus. Uterine receptivity, which can be affected by exposures such as to hydrosalpingeal fluid, is assumed to be independent of embryo viability. Both viability and receptivity are required for successful implantation; this simple formulation implies that implantation probability per transferred embryo is θ = πρ. One difficulty with inference from EU models is that both E i and U i are unobserved when S i = 0. Implications are addressed in detail in Sections 2.1, 3.1 and 3.2.
The EU model offers the possibility to study effects of exposure and other covariates on embryo viability and uterine receptivity separately. This is particularly relevant to studying the effect of hydrosalpinx, which is thought to affect implantation by compromising uterine receptivity, but not embryo viability. Baeten et al. (1993) use an EU model for epidemiologic IVF data in which ρ i is modeled as a function of covariates; Zhou and Weinberg (1998) further extend the EU model so that both ρ i and π i can be specified as functions of covariates including embryo-specific characteristics.
Despite clustering of embryo outcomes at the patient level, most analyses reported in the clinical literature-and current formulations of the EU model-assume independence between all embryo outcomes. It is well known that if the outcomes are correlated, variability in parameter estimates obtained under the assumption of independence will generally be biased (Diggle et al., 1994) .
In this paper, we describe a Bayesian hierarchical version of the EU model that naturally incorporates variation at both the embryo and patient level. Correlation between embryo viabilities is incorporated by directly modeling patient-level heterogeneity. A Gibbs sampling algorithm with a data augmentation step is described for dealing with missing E i and U i among those with S i = 0. We also show that regardless of whether patient-level heterogeneity in embryo viability is incorporated, informative prior distributions for key parameters are needed to obtain proper posteriors.
We use the model to investigate the role of hydrosalpinx using data from the WIH. Informative priors are constructed from previous applications of the EU model to other IVF studies. Several criteria are used to guide model selection. Model fit is critiqued by comparing observed data to the posterior predictive distribution. Our analysis indicates substantial patient level heterogeneity in embryo viability, suggesting the appropriateness of a multi-level model.
THE EU MODEL FOR EMBRYO IMPLANTATION
We use t i to denote the observed number of embryos transferred for woman i, where i = 1, . . . , n. The implantation status of embryo j transferred to woman i is represented by the Bernoulli random variable S i j , where j = 1, . . . , t i ; thus, the number of implantations observed is S i = t i j=1 S i j . Implantation is assumed to occur when a viable embryo is transferred to a receptive uterus. For subject i, E i j is a binary indicator of viability for the jth embryo selected for transfer, with associated viability at Pennsylvania State University on February 28, 2013 http://biostatistics.oxfordjournals.org/ Downloaded from probability π i j . The sum E i = j E i j denotes the number of viable embryos transferred to patient i. In addition, U i is the binary indicator of uterine receptivity for subject i, with associated probability ρ i . An embryo is viable (E i j = 1) if it would implant when transferred to a receptive uterus. Likewise, a uterus is said to be receptive (U i = 1) if a viable embryo would implant upon being transferred. Under these definitions, implantation requires both viability and receptivity, and the implantation status of embryo j transferred to woman i is S i j = E i j U i .
Previous formulations and applications of EU model
The EU model described by Speirs et al. (1983) and Walters (1985) is a two-parameter version that assumes embryo viability and uterine receptivity are constant across both patients and embryos (i.e. π i j = π and ρ i = ρ). Baeten et al. (1993) extend the model to include covariate effects in a logistic model for receptivity probability. Most recently, Zhou and Weinberg (1998) generalize the model to allow both embryo viability and uterine receptivity to depend on covariates through generalized linear models. Specifically, π i j and ρ i are tied to explanatory variables via
where x E i j (1 × P) and x U i (1 × Q) are vectors of covariates that affect embryo viability and uterine receptivity, respectively, and β and γ are the associated regression coefficients.
An inherent difficulty in fitting EU models is that for subjects with zero implantations, i.e. with S i = j S i j = 0, neither E i nor U i is observable. If S i > 0 then E i = S i and U i = 1 necessarily; however, if S i = 0, then either E i = 0, or U i = 0, or both. Baeten et al. (1993) show how to obtain maximum likelihood estimates directly from the observed data likelihood; Zhou and Weinberg (1998) take an EM algorithm approach (Dempster et al., 1997) .
Current formulations of the EU model make two important assumptions: (i) that embryo viability is independent of uterine receptivity, and (ii) that viabilities of individual embryos transferred to the same patient are independent. The first assumption allows convenient factorizations in the likelihood function and is relatively plausible from a clinical standpoint, especially when conditioning on covariates that are known to explain variation in both processes (such as age). The assumption that embryo viabilities are independent within patient may be more difficult to justify. For example, even after conditioning on observable covariates, viabilities will be correlated within patient if there exists patient heterogeneity due to unobservable or unmeasured factors such as genetic contributions to embryo viability.
A BAYESIAN HIERARCHICAL MODEL FOR IMPLANTATION
In this section we describe a hierarchical formulation of the EU model that allows for patient heterogeneity in embryo viability. Heterogeneity is modeled via individual patient effects in the regression model for the embryo viabilities, π i j ; these can be viewed as capturing variation due to unmeasured covariates. We also address several key issues related to implementing this model: posterior estimation, potential for improper posterior distribution, and model selection and model fit.
The hierarchical model can be written in three levels. At level I, we model the within-patient variation of embryo viabilities, π i j , conditional on individual effects α i . Building on (1), we assume a generalized linear model for embryo viability, conditional on α i , where g is a monotone function that maps (0, 1) to the real line, and z E i j (1 × R) and x E i j (1 × P) are possibly overlapping vectors of covariates. A simple case, and one we use in our application, sets z E i j = 1 for all j, giving scalar subject effects α i (patient-specific intercepts) that are used to capture patient level heterogeneity and (after integrating over α i ) positive correlation between embryo viabilities within patient.
Level II characterizes between-patient variability in both embryo viability (measured by α i ) and uterine receptivity, ρ i . The α i are assumed to follow a population distribution G indexed by parameters η. Uterine receptivity ρ i is modeled as a function of patient level covariates
where h is a smooth monotone link function like g and x U i and γ are exactly as in (1). Referring again to the current application, because hydrosalpinx is thought to influence embryo implantation by affecting the uterine environment, patient hydrosalpinx status can be included as part of x U i but omitted from x E i j . The parameter η also can depend on covariates; in our analysis in Section 4, we allow variance components that are part of η to depend on hydrosalpinx.
Level III is used to specify prior distributions for β, γ and η. Motivation for adopting informative priors is provided in Section 3.2, and details on construction of specific priors for our application are given in Section 4.2.
Posterior estimation from observed implantation data
Our inferences about the population parameters are based on their joint posterior distribution, which we draw using a Gibbs sampler with Metropolis steps (Metropolis et al., 1953; Geman and Geman, 1984; Gelfand and Smith, 1990) . It is possible to take two equivalent sampling approaches that differ in the choice of likelihood: the first approach uses the observed data likelihood, constructed directly by integrating over the missing E i j and U i for those patients with S i = 0; the second approach-which we adopt-uses the complete-data likelihood (i.e. the likelihood assuming E and U are fully observed), treats missing values as unknown parameters, and embeds a data augmentation step into the sampling algorithm. The second approach is analogous to an EM algorithm; an advantage for sampling is that full conditionals for population parameters are computationally simpler, because after conditioning on data and unobservable E i j and U i , the likelihood factors over β and γ.
and U mis similarly. Using ψ(·) to denote a prior distribution, the posterior distribution can be written as follows:
The first factor on the right-hand side is proportional to the complete-data likelihood. The second factor suggests the data augmentation scheme described above. For our analyses in Section 4, we take g and h to be logit functions, model between-subject variance with a subject-specific intercept α i , and utilize only subject-level covariate information (i.e. embryo-specific covariates are not available). For this case, E mis and U mis are drawn from their full conditionals as follows (recall that E and U are missing only when S = 0).
To draw E mis , note that its full conditional distribution This sampling scheme may be slow-mixing because of the high dimensionality of the space and potentially high correlation among some regression parameters. In our analysis of the IVF data, regression parameters for viability and for receptivity are sampled in two separate blocks to improve the mixing of the chain (Liu, 1994; Carlin and Louis, 2000) . We also center covariates to reduce correlation between regression parameters. Convergence of the chain is assessed using two separate criteria: one involving an approximation to Geweke's method (Spiegelhalter et al., 1996; Geweke, 1992) , and the other using comparison of within and between chain variability of multiple chains started at dispersed initial points (Gelman et al., 1995) .
A need for informative prior distributions
The inability to directly observe information on either uterine receptivity or embryo viability for patients with no implantations can lead to an improper posterior distribution under flat priors on the population parameters. We show that underlying uterine receptivity, captured by the intercept term γ 0 in h(ρ i ), can have an improper posterior under flat priors. To demonstrate this, we assume that g and h are logit link functions, and redefine x U i to be the matrix of covariates only (without the column of ones). Recall that S i = E i U i . Under the assumption that (i) viability is independent of receptivity and (ii) viabilities within subject are independent given α i , the probability model for S i given α i , as a function of π i (α i ) and ρ i , is
Let θ = (β, γ, η) represent the population parameters; the posterior of (θ, α) is given by
Under logit link functions,
.
Let θ −γ 0 denote the vector of all population parameters except γ 0 . Then, under a flat prior on γ 0 (meaning that ψ(γ 0 ) is proportional to a constant), the marginal posterior distribution of γ 0 is proportional to its full 
where
By evaluating the limit of (3) as γ 0 → ∞, it can be seen that the full conditional is not integrable in γ 0 , and hence the joint posterior of θ is improper. Clearly,
, meaning that the conditional posterior (3) is bounded away from zero as γ 0 → ∞.
The limiting value of the conditional in (3) does give some insight about how the data provide information on γ 0 for subjects with no implantations observed (i.e. S i = 0). For individuals who have large numbers of transfers (i.e. large t i ) but no implantations, P(U i = 1) diminishes. For smaller t i , it is more difficult to distinguish whether lack of viability or lack of receptivity (or both together) is responsible for the lack of implantations. In the extreme case where t i = 1 for all subjects, none of the model parameters is identifiable from observed data, even when setting α i = α; this occurs because it is not possible to identify unique π and ρ such that πρ = µ, where µ is the probability of observing an implantation. Informative prior distributions in our analysis are constructed from two previous applications of the EU model, as described in Section 4.2.
Model selection and model fit
We compare fit between models with and without variance components for subject-level variation, using posterior predictive loss and two additional criteria as well. The posterior predictive loss criterion (Gelfand and Ghosh, 1998) we use is based on squared-error loss. Related conceptually to the Akaike Information Criterion, this approach rewards optimal combinations of fit and parsimony. Let S rep i denote a draw from the posterior predictive distribution of S i . For model m, the posterior predictive loss under squared-error loss is
D(m) can be computed using the sampler output, as shown in Gelfand and Ghosh (1998) .
For completeness, we also compare models using 'pseudo-Bayes factors' (Gelfand and Dey, 1994 ) and a measure based on the classical notion of deviance (Gilks et al., 1993; Karim and Zeger, 1992) . The first of these compares predictive log-likelihoods between models (the harmonic mean of the likelihood values of replicate data sets drawn from their posterior predictive distribution); the ratio of predictive log-likelihoods can be viewed as a 'pseudo-Bayes factor.' The second one uses the posterior distribution of deviance; we compared both the mean and the minimum of the posterior distribution of the deviance measure across candidate models.
After deciding upon an appropriate model, we examine fit by comparing the observed data to its posterior predictive distribution, operationalized by comparing the observed frequencies of S i to their expected frequencies under posterior predictive distribution E(S 
ANALYSIS OF EMBRYO IMPLANTATION DATA
In this section, we formulate several versions of the hierarchical model for the data from the WIH, select one version for inference based on evaluating several model choice criteria, and examine its fit under several choices for prior distribution of underlying uterine receptivity (γ 0 ). We give a detailed description of how the informative priors are constructed from previous studies, and assess sensitivity of inferences about the population parameters to choice of prior. Our primary focus is on measuring the extent to which hydrosalpinx affects implantation by altering uterine receptivity.
The estimated marginal implantation probability is 36/310, or 11.6% among women with hydrosalpinx compared to 105/782, or 13.4% among women without (crude odds ratio 0.85). Those with and without hydrosalpinx are similar based on age, number of transfers, number of oocytes retrieved, and implantation rate conditional on t i (Table 1) .
Model specifications
We use hydrosalpinx status and age in the model for uterine receptivity, and include age and number of untransferred embryos as covariates in the model for embryo viability. Age is an important determinant of the overall health of both uterus and embryos, because women over 35 years of age are thought to be more highly susceptible to chromosomal and endometrial abnormalities. Because embryo-specific covariates are unavailable in this study, number of untransferred embryos is used as a proxy of embryo quality; the justification is that when a high number of embryos is available for transfer, the embryologist has a greater number of choices when identifying those most suitable for transfer. This variable, abbreviated as UTE for 'untransferred embryos', is dichotomized according to whether ten or more embryos remain after the transfer. 
where, for woman i, H i = 1 if she has hydrosalpinx and −1 otherwise; A i = 1 if the woman is older than 34 years of age and −1 otherwise; and UTE i = 1 if there are 10 or more embryos remain after transfer and −1 otherwise. Three formulations of the second level are considered:
Model 1 sets α i = α, implying that all embryos are independent within subjects. This model assumes that embryo viabilities are not correlated within subjects and that there is no patient-level heterogeneity. This model is the Zhou and Weinberg (1998) model. Model 2 assumes that subject effects α i come from a normal distribution with mean α and variance τ −2 .
This model induces positive correlation in embryo viability outcomes within the same couple after integrating out the subject effects. Model 3 also assumes that α i are normally distributed, but allows var(α i ) to differ by hydrosalpinx exposure. In other words,
k ), where k ∈ {0, 1} indicates whether woman i has hydrosalpinx. This model induces separate correlation structures in embryo viability outcomes within couples with and without hydrosalpinx. This third specification was considered because fitting the EU model 2 separately by hydrosalpinx status yielded vastly different posterior distributions for var(α i ).
Formulating priors and assessing sensitivity to choice of prior
Diffuse normal priors with variances of 10 3 are used for elements of β, γ and α, with the exception of the intercept γ 0 in the receptivity model. Gamma priors G(0.01, 0.01) are used for precision parameters τ 2 = 1/var(α i ).
We place an informative prior N (µ γ 0 , ν 2 γ 0 ) on γ 0 , ranging its mean between the estimated valuesĝ 1 andĝ 2 of the same parameter from two previous applications of the EU model (Baeten et al., 1993; Zhou and Weinberg, 1998) . Both estimates are derived from models that assume independence between embryo viabilities within patients (as in model 1). The prior mean for γ 0 , denoted µ γ 0 , is wĝ 1 + (1 − w)ĝ 2 , where w ∈ [0, 1] allows µ γ 0 to take on any value betweenĝ 1 andĝ 2 .
The value forĝ 1 is taken from an analysis of data from the North Carolina IVF study (Zhou and Weinberg, 1998) . The model for uterine receptivity included age as a covariate, so we computedĝ 1 as the intercept corresponding to the mean age of women in our study. Specifically, the receptivity model fit to the North Carolina data has estimated intercept 1.38 and (uncentered) age coefficient −0.05; we derived g 1 = −0.35 as the intercept corresponding to age 34.6 years, the mean age in our sample. The valuê g 2 = 0.62 is derived in a similar way using a model fit to IVF data from St Luc Hospital in Belgium (Baeten et al., 1993) . We assigned prior variance ν 2 γ 0 = 4, which was found to be the most diffuse prior yielding consistent stability in the sampling algorithm. Larger values of the variance ν 2 γ 0 lead to flatter posteriors, resulting in increased problems with implementation of MCMC algorithms. This upper bound 4, however, exceeds what would be obtained using standard errors of the estimates in the two models used to deriveĝ 1 andĝ 2 .
To assess sensitivity of estimates to choice of prior on γ 0 , we ran 60 Gibbs samplers with w ∈ {0, 0.25, 0.5, 0.75, 1} and with ν 2 γ 0 varied between 0.25 and 4. These values of w correspond to population receptivity proportions ρ ∈ {0.65, 0.59, 0.53, 0.47, 0.41} when all other covariates in the receptivity model are set to zero. In addition, following the suggestion of a referee, to further explore the sensitivity of the posterior estimates to the choice of priors, we re-fit model 3 for a variety of different values of the prior variance for α, γ 0 , and the τ 2 k . Additionally, keeping in mind that diffuse normal priors on regression parameters in log odds scale place most of the prior mass near 0 and 1 on the probability scale (ρ and π ) when covariates are centered at zero, priors with smaller variances may be more appropriate because they are less informative on the probability scale. To investigate the possible implications for our application, we re-fit model 3 using N (0, 1), N (0, 2), and N (0, 3) priors on γ 0 and a N (0, 4) prior on α. To investigate the role of the variance component priors, we re-fit model 3 using G(1, 1) prior on each τ 2 k , which is much less diffuse than G(0.01, 0.01).
Summary of results and inference for EU models
As a preliminary step, we carried out an empirical check for overdispersion relative to independent binomial distribution among the E i = j E i j across all subjects (conditional on covariates). Under the model assumption that E i is independent of U i , it is possible to construct a Pearson-type measure of overdispersion from those patients with observable E i , i.e. those with U i = 1 and E i > 0, or equivalently,
where n + is the number of patients with both S i > 0 and t i > 1, p is the number of model parameters, µ
and V + i from Model I are used to calculate H ; those with t i = 1 are excluded because V + i = 0. Under no overdispersion we expect H to be near 1; for the IVF data, n + = 74, p = 6, and H = 108/68 = 1.6. Assuming the usual asymptotics hold and treating the numerator of H as a chi-square statistic on 68 d.f., the associated p-value under no overdispersion is 0.002.
We then fit separate models to data from women with and without hydrosalpinx. The parameter estimates indicated little support for including interaction terms in x E i and x U i ; however, we observed a substantial difference in patient heterogeneity. Women with hydrosalpinx are apparently more homogeneous with respect to embryo viability. For example, in fitting the separate models using vague gamma priors for the inverse variance of α i , and using µ γ 0 = 0.62, the 95% highest posterior density (HPD) interval for standard deviation of embryo viabilities among women without hydrosalpinx is (0.91, 1.84), but for those with hydrosalpinx, the interval is (0.10, 1.19). This provides an empirical motivation for considering model 3. A possible explanation for this difference in variation is that women without hydrosalpinx may be presenting with a broader variety of viability-related indications for IVF beyond their existing tubal disease, leading to greater heterogeneity.
For the combined sample, Table 2 summarizes model choice criteria for w ∈ {0, 0.5, 1} and ν 2 γ 0 = 4. For each choice of w, each of the model selection criteria favors model 3; furthermore, it is clear that model 1, which assumes no correlation between viabilities, is an inferior choice compared to models 2 and 3. Although our inferences are based on model 3, we include for comparison bootstrap estimates of confidence intervals for model 1 (Table 3 ). The 2500 bootstrap samples are drawn at the subject level to account for extra variability due to clustering. Confidence intervals are computed using bootstrap standard errors and assuming that the maximum likelihood estimates for model 1 are approximately normally distributed. For each parameter, the bootstrap confidence intervals are wider than those computed under the independence assumption, suggesting that inferences under independence may understate uncertainty. This bootstrap analysis appears to do reasonably well for drawing inference about hydrosalpinx in presence of clustering. Table 3 summarizes the posterior means and 95% HPD regions for population parameters in model 3, and includes the same from model 1 for comparison. There is little indication that hydrosalpinx affects uterine receptivity, but the posterior distribution of γ 1 has substantial variance; its 95% HPD interval when w = 0 is (−0.47, 0.54) ; the marginal posterior distribution of γ 1 is nearly unchanged across various choices for the prior of γ 0 as can be seen in Table 3 . In fact, the joint posterior distribution of (γ 0 , γ 1 ) seems to vary most substantially along the γ 0 axes (Figure 1 ), suggesting that γ 0 is most affected by the changes in w (as expected).
Having ten or more embryos remaining after transfer (UTE = 1) does appear to be an important marker of embryo viability; the posterior mean of β 1 is 0.3 with 95% HPDI (0.01, 0.59) under w = 0. Posterior distributions of the age effects β 2 and γ 2 indicate that age may affect embryo viability to a greater degree than uterine receptivity (especially for w = 0 and w = 0.5). The posterior medians of the standard deviations τ −1 0 and τ −1 1 differ roughly by a factor of 3 across choices of w. At w = 0, their respective 95% HPD intervals are (0.74, 1.68) and (0.00, 0.91). As expected, HPD intervals for coefficients in the viability model are substantially wider in model 3 compared to model 1; interestingly, it appears that the added variation is also reflected in the submodel for uterine receptivity.
Regarding sensitivity to prior distributions, we found that the posterior distributions of both γ 0 and α are quite sensitive to the choice of µ γ 0 (quantified through w); this is not surprising given that these two parameters are inversely related and that γ 0 is only weakly identified. Following the sensitivity analyses described at the end of Section 4.2, we did not find the posterior distributions of other regression parameters to be particularly sensitive either to the prior mean or variance of γ 0 , nor to the prior variances of α and the τ 2 k . In particular, the posterior of γ 1 , which is of primary scientific interest in this study, indicates very little evidence of hydrosalpinx effect, regardless of choice of prior for the parameters τ 2 k , α, and γ 0 .
The two submodels for viability and receptivity do not necessarily capture the relationship between covariates and eventual implantation; one way to visualize these effects is through the use of a contour plot; we use UTE to illustrate. Figure 2 shows two contour plots of the joint posterior of (π, ρ), corresponding respectively to UTE = −1 and UTE = 1. The contours in the two graphs in Figure 2 correspond to the hyperbolae of constant implantation rates, i.e. πρ = constant. The joint posterior of (π, ρ) appears shifted upwards and to the right in the second contour plot, meaning that women with ten or more embryos remaining after the transfer stand greater chance of implantation. Specifically, the joint posterior is centered close to the contour of 0.1 for UTE = −1 and close to 0.2 when UTE = 1, indicating that the average probability of embryo implantation roughly differs by a factor of 2 between the two populations. (ρ, π) . Contours represent the loci of constant probability of implantation (ρπ). The contour plot on the left corresponds to having less than 10 embryos remaining after the transfer. The plot on the right corresponds to having 10 or more embryos left over. In both plots, it is assumed that no hydrosalpinx is present and that women are younger than 35 years of age. The model is fit using w = 0 (prior mean of γ 0 = 0.62).
MA). The chains were run for 20 000 iterations (each took around 40 min running on a Sun Ultra-4). With the parametrization we employed (centered covariates and centered subject effects) and sampling in blocks for the regression parameters, the autocorrelation was very low and the convergence was relatively quick (all chains stabilized within the first 2000 iterations, which we discarded).
DISCUSSION
We describe a Bayesian hierarchical framework for modeling embryo implantation following IVF; our approach extends the EU model, where the implantation is assumed to occur when a viable embryo is transferred to a receptive uterus. Our approach builds upon the regression framework developed by Zhou and Weinberg (1998) to include subject-level variation in embryo viability, thereby accounting for correlation between embryo outcomes within subject. Because both viability and receptivity data are missing for women with zero implantations, posterior distributions of some parameters are improper under flat prior distributions, thus motivating the need for well-chosen informative prior distributions.
The hierarchical formulation confers several advantages. First, because embryos from the same woman/couple inevitably share unmeasured characteristics (genetic, environmental, etc.) that affect viability, the multi-level specification is a natural device to capture within-subject correlation induced by patient-level heterogeneity. Second, IVF data tend to be clustered at many levels and the hierarchical formulation extends naturally to datasets containing multiple IVF cycles, practitioners, and IVF clinics, and is able to address each of the variability sources separately. Finally, even though the twocomponent model is justified by biological considerations, in analyses involving one cycle, data will inform only weakly about underlying uterine receptivity, providing clear motivation for adopting the Bayesian framework as a means to use prior information gathered from other studies or from clinical expertise.
If the sole objective of modeling is to infer regression parameters in the presence of clustering, other methods could be used, including alternative model specifications for patient-level variation (e.g. beta-binomial) or, in a frequentist mode, variance calculations that take clustering into account (e.g. sandwich estimators). Our bootstrap confidence intervals are in the spirit of the latter. When objectives may be more broad, such as predicting pregnancy for an individual on a future cycle, the multi-level formulation is more useful because the effects of unmeasured patient-level characteristics are explicitly modeled.
Understanding which factors affect embryo quality and uterine environment is of high importance in IVF research. In this study, we did not find evidence that hydrosalpinx affects uterine receptivity, but high variability in the posterior distribution of γ 1 suggests that data from more subjects may be needed to estimate this effect more precisely. Our analysis of implantation data from WIH indicates substantial patient-level heterogeneity, which is reflected in wider HPD intervals of key population parameters.
Two important issues warrant further developments: incorporating embryo-specific covariates, such as rate of cleavage and other physical characteristics observable under high-powered magnification, and utilizing data from repeated IVF cycles. In principle, our model can be extended to include embryospecific covariates, but this is not straightforward because when 0 < S i < t i it is not possible to link implantation status to individual embryos. Zhou and Weinberg's 1998 formulation does allow for embryolevel covariates; the E step of their EM algorithm takes expectations by averaging over all possible permutations of {E i j } given S i and t i . For the hierarchical model, embryo level covariates can be incorporated in posterior estimation by adding another step in the sampler that draws individual embryo outcomes from their full conditional distributions.
The facility to handle repeated cycles also is important. Patients discontinue IVF for a variety of reasons that may include financial, clinical, and psychological considerations. Furthermore, many subjects who succeed at IVF do not return for further cycles (see Zhou and Weinberg, 1999 for a review) . A hierarchical approach is attractive in the sense that extending to multiple cycles can be accomplished by adding another level of variation for cycle-to-cycle variability. Additionally, using data from multiple cycles may give the opportunity to capture patient-level heterogeneity in uterine receptivity.
Finally, we note that although the term 'EU model' comes from IVF applications, models with the same general structure are used to analyze outcomes in other areas of reproductive medicine. Examples include modeling the probability of conception as a function of the timing and frequency of intercourse (Zhou et al., 1996; Dunson and Weinberg, 2000a,b; Wilcox et al., 1995; Weinberg et al., 1994) . In this setting, one or more occurrences of intercourse are possible during each menstrual cycle. Each occurrence results in a binary outcome (conception or no conception), and the cycle is said to be either viable or not. When conception does not occur, it is not possible to know whether the cycle is non-viable or intercourse is poorly timed. Drawing an analogy to the IVF setting, proper timing of an act of intercourse is similar to the viabilities (E), and cycle viability is similar to receptivity (U ). Hence EU-type models have broad applicability in infertility research.
